| PF00001 |
7 transmembrane receptor (rhodopsin family) |
162 |
4.7 |
4.2x10-41
|
| PF00017 |
SH2 domain |
56 |
1.6 |
2.2x10-14
|
| PF07714 |
Protein tyrosine kinase |
65 |
1.9 |
1.1x10-12
|
| PF00520 |
Ion transport protein |
53 |
1.5 |
2.6x10-10
|
| PF00018 |
SH3 domain |
49 |
1.4 |
2.4x10-8
|
| PF00069 |
Protein kinase domain |
121 |
3.5 |
4.8x10-8
|
| PF00104 |
Ligand-binding domain of nuclear hormone receptor |
28 |
0.8 |
4.1x10-6
|
| PF13895 |
Immunoglobulin domain |
32 |
0.9 |
6.5x10-6
|
| PF00105 |
Zinc finger, C4 type (two domains) |
26 |
0.8 |
4.2x10-5
|
| PF10613 |
Ligated ion channel L-glutamate- and glycine-binding site |
15 |
0.4 |
5.6x10-5
|
| PF00060 |
Ligand-gated ion channel |
15 |
0.4 |
5.6x10-5
|
| PF01582 |
TIR domain |
16 |
0.5 |
1.2x10-4
|
| PF00211 |
Adenylate and Guanylate cyclase catalytic domain |
16 |
0.5 |
1.2x10-4
|
| PF00619 |
Caspase recruitment domain |
17 |
0.5 |
1.9x10-4
|
| PF02931 |
Neurotransmitter-gated ion-channel ligand binding domain |
23 |
0.7 |
4.1x10-4
|
| PF02932 |
Neurotransmitter-gated ion-channel transmembrane region |
23 |
0.7 |
4.1x10-4
|
| PF00229 |
TNF(Tumour Necrosis Factor) family |
14 |
0.4 |
7.6x10-4
|
| PF00020 |
TNFR/NGFR cysteine-rich region |
15 |
0.4 |
1.2x10-3
|
| PF00041 |
Fibronectin type III domain |
49 |
1.4 |
1.3x10-3
|
| PF00045 |
Hemopexin |
16 |
0.5 |
1.7x10-3
|
| PF00102 |
Protein-tyrosine phosphatase |
21 |
0.6 |
2.2x10-3
|
| PF00433 |
Protein kinase C terminal domain |
18 |
0.5 |
2.3x10-3
|
| PF00595 |
PDZ domain (Also known as DHR or GLGF) |
45 |
1.3 |
5.2x10-3
|
| PF00413 |
Matrixin |
15 |
0.4 |
6.2x10-3
|
| PF01471 |
Putative peptidoglycan binding domain |
14 |
0.4 |
0.011 |
| PF00005 |
ABC transporter |
24 |
0.7 |
0.014 |
| PF00019 |
Transforming growth factor beta like domain |
19 |
0.6 |
0.019 |
| PF00130 |
Phorbol esters/diacylglycerol binding domain (C1 domain) |
24 |
0.7 |
0.021 |
| PF00230 |
Major intrinsic protein |
10 |
0.3 |
0.031 |
| PF00664 |
ABC transporter transmembrane region |
14 |
0.4 |
0.042 |
